New drug
candidate shows promise against cancer
Platinum
compound may offer an alternative to cisplatin, a widely used chemotherapy
agent.
Drugs
containing platinum are among the most powerful and widely used cancer drugs.
However, such drugs have toxic side effects, and cancer cells can eventually
become resistant to them.
MIT
chemistry professor Stephen J. Lippard, who has spent much of his career
studying platinum drugs, has now identified a compound that kills cancer cells
better than cisplatin, the most commonly used platinum anticancer drug. The new
compound may be able to evade cancer-cell resistance to conventional platinum
compounds.
read more: